跳至主要内容
临床试验/jRCTs042240139
jRCTs042240139招募中不适用

Prospective randomized control trial analyzing the efficacy of LithoVue Elite on postoperative infection of endoscopic combined intrarenal surgery (ECIRS) (Elite ECIRS-2023)

未提供0 个研究点目标入组 150 人开始时间: 2025年2月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
主要终点
Incidence of postoperative fever

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Single Blind

入排标准

年龄范围
20age old over 至 85age old under(—)
性别
All

入选标准

  • •Patients who will be performed ECIRS for upper tract urinary calculi at the Nagoya City University Hospital or Ngaoya City University East Medical Center
  • •Age at the time of informed consent is between 25 and 85 years old
  • •Written informed consent from patient to participate in the study, including compliance with study procedures

排除标准

  • •Patients with coagulation abnormality or unable to discontinue anticoagulants
  • •Pregnant or possibly pregnant or breastfeeding women
  • •Patients who are not be able to do general anesthesia
  • •Patients unable to maintain the surgical position (prone split-leg position)
  • •Patients with active febrile urinary tract infection
  • •Patients after urinary diversion
  • •Patients with preoperative nephrostomy insertion
  • •Patients who cannot be inserted ureteroscopy due to severe ureteral stricture
  • •Other patients for whom the investigator or sub-investigator judges the subject to be inappropriate

结局指标

主要结局

Incidence of postoperative fever

时间窗: during hospitalization

a temperature >38.5 for at least 1 day or >38.0 for more than 2 days

次要结局

  • Number of SIRS criteria
  • quick SOFA (qSOFA)
  • Intraoperative inflammatory markers(Intraoperative)
  • Postoperative Inflammatory marker(Postoperative)
  • Postoperative complications(Postoperative)

研究者

发起方
未提供

相似试验